Evaluation of AI Models in Determining the Optimal PEEP
Evaluation of the Success of Artificial Intelligence Models in Determining the Optimal Positive End-Expiratory Pressure (PEEP) in Mechanical Ventilation in Intensive Care
1 other identifier
observational
145
1 country
1
Brief Summary
his study is designed as a prospective observational clinical trial. Patients over 18 years old who are hemodynamically stable and require mechanical ventilation in the Intensive Care Unit (ICU) will be included. The inclusion criteria ensure that participants require individualized ventilatory optimization. The study will involve a comparison between Artificial Intelligence (AI)-generated Positive End-Expiratory Pressure (PEEP) recommendations and expert-determined PEEP levels. ICU specialists will perform PEEP titration manually based on standardized protocols, identifying the lower inflection point (LIP) and upper inflection point (UIP) to optimize ventilation. The pressure-volume (P-V) curve will be analyzed to ensure optimal alveolar recruitment and prevent overdistension. Study Procedures Participants will: Undergo systematic mechanical ventilation assessments, including inspiratory hold and expiratory hold maneuvers, compliance, elastance, auto-PEEP, and time constant evaluations. Have ventilation data collected and analyzed using three AI models: ChatGPT, DeepSeek, and Gemini. Receive AI-generated recommendations regarding optimal PEEP levels, abnormal ventilation parameters, and potential treatment suggestions. Have their AI-based PEEP recommendations compared with those determined by ICU specialists with at least five years of experience. Outcome Measures The study will compare AI and expert assessments based on the following primary and secondary measures: Primary Outcome: Agreement between AI-generated PEEP levels and expert-determined PEEP levels. Secondary Outcomes: AI sensitivity and specificity in detecting abnormal ventilation parameters. Accuracy of AI-generated diagnoses. Clinical applicability of AI-recommended treatment strategies. This study aims to determine whether AI models can serve as reliable clinical decision support tools for ventilator management in ICU patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2025
CompletedFirst Posted
Study publicly available on registry
February 25, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2026
CompletedJune 4, 2025
May 1, 2025
11 months
February 20, 2025
May 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Agreement Between AI-Generated and Expert-Determined PEEP Levels
The primary outcome will be the agreement between the PEEP levels recommended by AI models (ChatGPT, DeepSeek, Gemini) and those determined manually by ICU specialists. Agreement will be assessed using Bland-Altman analysis and intraclass correlation coefficient (ICC) to measure consistency
7 day
Secondary Outcomes (3)
Sensitivity and Specificity of AI Models in Detecting Abnormal Ventilation Parameters
7 days
Accuracy of AI-Generated Diagnostic Predictions
7 days
Clinical Applicability of AI-Generated Treatment Recommendations
Within the first 24 hours of mechanical ventilation.
Study Arms (2)
AI-Generated PEEP Group (Experimental Group)
Patients in this group will have their optimal PEEP levels determined using AI models (ChatGPT, DeepSeek, and Gemini). AI models will analyze mechanical ventilation data, including compliance, elastance, auto-PEEP, time constant, and pressure-volume (P-V) curves, to generate PEEP recommendations. These AI-generated values will be recorded and analyzed for accuracy, clinical relevance, and agreement with expert decisions.
Expert-Determined PEEP Group (Control Group)
In this group, PEEP titration will be performed manually by ICU specialists using standard clinical protocols. Experts will determine PEEP levels based on lower and upper inflection point identification and pressure-volume curve analysis. Their decisions will serve as the reference standard for evaluating the AI-generated recommendations.
Interventions
In this study, three artificial intelligence (AI) models (ChatGPT, DeepSeek, and Gemini) will analyze mechanical ventilation data, including compliance, elastance, auto-PEEP, time constant, and pressure-volume (P-V) curves, to generate patient-specific PEEP recommendations. These AI-generated recommendations will be compared with manual PEEP titration performed by experienced ICU specialists. The AI models will also provide abnormal ventilation parameter detection, diagnostic suggestions, and treatment recommendations. The study aims to evaluate the reliability, accuracy, and clinical applicability of AI-generated outputs in optimizing PEEP settings for mechanically ventilated ICU patients.
Eligibility Criteria
This study will include adult patients (≥18 years old) requiring mechanical ventilation in the intensive care unit (ICU). The target population consists of hemodynamically stable patients who require individualized ventilator management and PEEP titration for optimized respiratory support.
You may qualify if:
- Patients aged 18 years or older (adult patient group).
- Patients requiring mechanical ventilation in the intensive care unit (ICU).
- Hemodynamically stable patients with stable blood pressure and heart rate.
- Patients with complete medical records, including arterial blood gas values and ventilation parameters.
- Patients whose legal representatives (if applicable) have provided informed consent for study participation.
You may not qualify if:
- Patients receiving extracorporeal membrane oxygenation (ECMO).
- Patients with severe hemodynamic instability, such as refractory hypotension or arrhythmias requiring continuous vasopressor support.
- Patients with incomplete medical records, particularly those missing critical data on ventilation parameters or arterial blood gas analysis.
- Patients or their legal representatives who decline participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital
Istanbul, 34303, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 7 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- anesthesiology and reanimation specialist
Study Record Dates
First Submitted
February 20, 2025
First Posted
February 25, 2025
Study Start
March 1, 2025
Primary Completion
February 1, 2026
Study Completion
February 2, 2026
Last Updated
June 4, 2025
Record last verified: 2025-05